Iopromide (Ultravist)
Iopromide
Bayer (Pty) Ltd û Isando
Registration
- Applicant
- Bayer (Pty) Ltd û Isando
- Registrations
- 12
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Ultravist 300 75 ML EACH 1,0 ml SOLUTION CONTAINS IOPROMIDE 623,4 mg | 75 ml 300 | 28064228/28/0642 | Registered | S4 | None |
| Ultravist 370 200 ML EACH 1,0 ml SOLUTION CONTAINS IOPROMIDE 0,769 g | 200 ml 370 | 28064328/28/0643 | Registered | S4 | None |
| Ultravist 300 200 ML EACH 1,0 ml SOLUTION CONTAINS IOPROMIDE 623,40 mg | 200 ml 300 | 33008233/28/0082 | Registered | S4 | None |
| Ultravist 300 500 ML EACH 1,0 ml SOLUTION CONTAINS IOPROMIDE 623,40 mg | 500 ml 300 | 33008333/28/0083 | Registered | S4 | None |
| Ultravist 370 500 ML EACH 1,0 ml SOLUTION CONTAINS IOPROMIDE 768,86 mg | 500 ml 370 | 33008433/28/0084 | Registered | S4 | None |
| Ultravist 300 125 ML EACH 1,0 ml SOLUTION CONTAINS IOPROMIDE 0,623 g | 125 ml 300 | 46010946/28/0109 | Registered | S4 | None |
| Ultravist 370 125 ML EACH 1,0 ml SOLUTION CONTAINS IOPROMIDE 0,769 g | 125 ml 370 | 46011046/28/0110 | Registered | S4 | None |
| Ultravist 300 20ml EACH 1 ml SOLUTION CONTAINS IOPROMIDE 623 mg | 20ml 300 | V0175V/28/175 | Registered | S4 | None |
| Ultravist 300 50ml EACH 1 ml SOLUTION CONTAINS IOPROMIDE 623 mg | 50ml 300 | V0176V/28/176 | Registered | S4 | None |
| Ultravist 300 100ml EACH 1 ml SOLUTION CONTAINS IOPROMIDE 623 mg | 100ml 300 | V0177V/28/177 | Registered | S4 | None |
| Ultravist 370 50ml EACH 1,0 ml SOLUTION CONTAINS IOPROMIDE 769,0 mg | 50ml 370 | V0178V/28/178 | Registered | S4 | None |
| Ultravist 370 100ml EACH 1 ml SOLUTION CONTAINS IOPROMIDE 769 mg | 100ml 370 | V0179V/28/179 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Iopromide
S4: Iopromide
Consolidated Schedules 06 July 2026, line 6792
Pharmacological class: Contrast media (class 28)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
This product's active ingredient could not be matched to a single known compound.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.